People: Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

104.39USD
26 Feb 2015
Change (% chg)

$-2.27 (-2.13%)
Prev Close
$106.66
Open
$106.36
Day's High
$106.90
Day's Low
$102.38
Volume
402,986
Avg. Vol
714,476
52-wk High
$111.49
52-wk Low
$47.03

Search Stocks

Maraganore, John 

Brief Biography

Dr. John M. Maraganore, Ph.D., is Chief Executive Officer, Director of Alnylam Pharmaceuticals, Inc. Dr. Maraganore also served as the President from December 2002 to December 2007. From April 2000 to December 2002, Dr. Maraganore served as Senior Vice President, Strategic Product Development for Millennium Pharmaceuticals, Inc. (now a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited), a biopharmaceutical company. He also serves as a director of Regulus Therapeutics Inc. and the Biotechnology Industry Organization.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,101,330 -- 5,134,790 6,236,120

Options Compensation

  Quantity Market Value
Exercisable 764,108 7,795,030.00
Unexercisable 357,206 2,292,970.00
Exercised 191,612 8,927,830.00
Name Fiscal Year Total

John Clarke

--

Barry Greene

3,983,370

John Maraganore

6,236,120

Akshay Vaishnaw

1,747,850

Pushkal Garg

--

Michael Mason

500,850
As Of 30 Dec 2013
Search Stocks